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Background: Listeria monocytogenes lipoteichoic acid is synthesized by the LtaP/LtaS two-enzyme system.
Results: Structural analysis reveals a second glycerolphosphate binding site in LtaS important for in vitro and in vivo enzyme
function.
Conclusion: These results suggest a binding mode for the lipoteichoic acid chain during polymerization.
Significance: The identified binding site in LtaS could become a target for antibiotic development.
Lipoteichoic acid (LTA) is an important cell wall component
required for proper cell growth inmanyGram-positive bacteria.
InListeriamonocytogenes, two enzymes are required for the syn-
thesis of this polyglycerolphosphate polymer. The LTA primase
LtaPLm initiates LTA synthesis by transferring the first glycerol-
phosphate (GroP) subunit onto the glycolipid anchor and the
LTA synthase LtaSLm extends the polymer by the repeated addi-
tion of GroP subunits to the tip of the growing chain. Here, we
present the crystal structures of the enzymatic domains of
LtaPLm and LtaSLm. Although the enzymes share the same fold,
substantial differences in the cavity of the catalytic site and
surface charge distribution contribute to enzyme specializa-
tion. The eLtaSLm structure was also determined in complex
with GroP revealing a second GroP binding site. Mutational
analysis confirmed an essential function for this binding site
and allowed us to propose a model for the binding of the
growing chain.
Lipoteichoic acid (LTA)3 is an important cell wall compo-
nent found in many Gram-positive bacteria, including human
pathogens such as Staphylococcus aureus and Listeria mono-
cytogenes. In its absence, bacteria are impaired in growth and
show cell morphology and cell division defects (1–3). There-
fore, enzymes involved in its synthesis are attractive targets
for the design of new antimicrobials. This has been experi-
mentally validated with the identification of a small molecule
LTA synthesis inhibitor that prevented the growth of antibi-
otic-resistant Gram-positive bacteria as well as prolonging
the survival of mice challenged with a lethal dose of S. aureus
(4).
A common type of LTA consists of a linear 1,3-linked
polyglycerolphosphate (PGP) polymer that is attached to the
outside of the membrane via a glycolipid anchor (5, 6). In L.
monocytogenes, the glycolipids anchor is Gal(1–2)-Glc(1–
3)-diacylglycerol (Gal-Glc-DAG) or Gal(1–2)Ptd-6-Glc(1–
3)-DAG (Gal-Ptd-6Glc-DAG), in which the glucose moiety is
lipidated with an additional phosphatidyl (Ptd) group (5, 7, 8).
The PGP backbone chain is polymerized by lipoteichoic acid
synthase or LtaS-type enzymes (1). This class of enzyme uses
the membrane lipid phosphatidylglycerolphosphate (PG) as a
substrate, hydrolyzes the glycerolphosphate (GroP) head group
of this lipid and subsequently adds it to the tip of the growing
chain (9, 10). In S. aureus only one enzyme, namely LtaSSa, is
required for LTA backbone synthesis. This enzyme initiates
LTA synthesis by the transfer of the first GroP subunit onto the
glycolipid anchor and subsequently polymerizes the backbone
chain by the repeated addition of GroP subunits (1, 11). In con-
trast, L. monocytogenes uses a two-enzyme system for LTA syn-
thesis (3). The lipoteichoic acid primase LtaPLm transfers the
initial GroP subunits to the glycolipid anchor but is unable to
extend the chain further. Chain polymerization is performed by
the lipoteichoic acid synthase LtaSLm (3).
Regardless of whether LTA synthase or primase, LtaS-type
enzymes, have the same overall architecture. They are com-
posed of an N-terminal domain with five transmembrane heli-
ces, which is followed by an extracellular C-terminal domain
(eLtaS) containing the catalytic site (recently reviewed in Ref.
12). For many organisms, including the human pathogens S.
aureus, Staphylococcus epidermidis, L. monocytogenes, and
Bacillus anthracis, it has been shown that LtaS is cleaved by an
endogenous peptidase and a fraction of the extracellular eLtaS
is released into the culture supernatant as well as partially
retained within the cell wall fraction (3, 13–16). In vitro, the
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extracellular eLtaS has been shown to be sufficient for PG
hydrolysis (11, 17). However, expression of the extracellular
enzymatic domain is not sufficient for LTA production in vivo
and the full-length membrane embedded LtaS protein is
required for polymer production (16).
The structures of the extracellular enzymatic eLtaS domains
of the S. aureus (PDB code 2W5Q) and B. subtilis (PDB code
2W8D) have been reported (13, 18). These previous studies
showed that the enzymes are related to arylsulfatase family
enzymes with the same /-barrel fold. A conserved metal
binding site was revealed and its requirement for enzyme func-
tion confirmed experimentally (13). In addition, a Thr amino
acid within the active center was identified as the catalytic res-
idue and its essential role was confirmed as an LtaSSa-T300A
variant was enzymatically inactive both in vitro and in vivo (13).
The active site Thr was found to be phosphorylated in the B.
subtilis and unmodified in the S. aureus structure, but the bio-
logical significance of this modification has not yet been deter-
mined. It was further hypothesized that the reaction proceeds
through a covalentGroP-enzyme intermediate through the cat-
alytic Thr (13).
To understand better the reaction mechanism and enzyme
specificity of this class of proteins, we performed a structural
analysis of the extracellular soluble domains of the twoL.mono-
cytogenes enzymes eLtaPLm and eLtaSLm. This analysis revealed
a substantially smaller cavity around the catalytic center in the
primase enzyme compared with the synthase enzyme. The
eLtaSLm structure was also determined in complex with GroP.
This led to the identification of a second GroP binding site in
eLtaSLm that is essential for enzyme function. Detailed bioin-
formatics analyses revealed specific motifs that differentiate
LtaS and LtaP enzymes and highlighted that primase-related
enzymes are only present in a small subset of bacteria. Taken
together the structural and functional data allowed us to pro-
pose a revised mechanism for LTA biosynthesis in Gram-posi-
tive bacteria.
EXPERIMENTAL PROCEDURES
Plasmid and Strain Construction—Strains and primers used
in this study are listed in Tables 1 and 2, respectively. Esche-
richia coli strains were grown in LB medium and L. monocyto-
genes strains in BHI medium. The cultures were grown at the
TABLE 1
Bacterial strains used in this study
Antibiotics were used at the following concentrations: for E. coli cultures: Ampicillin (AmpR) 100 g/ml; kanamycin (KanR), 30 g/ml; tetracycline (TetR), 10 g/ml; for
L. monocytogenes cultures: chloramphenicol (CamR), 7.5 g/ml; streptomycin, 200 g/ml (StrepR) for conjugation experiments.
Strain Relevant features Reference
Escherichia coli strains
XL1 Blue Cloning strain, TetR – ANG127 Stratagene
SM10 E. coli strain used for conjugations; KanR – ANG618 40
DH-E898 XL1 Blue pPL3; L. monocytogenes integration vector; CamR – ANG1276 41
ANG1401 XL1 Blue pPL3-lmo0927His6; Lmo0927 (LtaSLm) with C-terminal His-tag under native
promoter control; CamR
3
ANG1449 DH5 pProEX-eLtaSLm; plasmid for expression of eLtaSLm; AmpR 11
ANG1478 Rosetta pProEX-eLtaPLm; strain for overexpression of eLtaPLm; AmpR 11
ANG1479 Rosetta pProEX-eLtaSLm; strain for overexpression of eLtaSLm; AmpR 11
ANG2930 XL1-Blue pPL3-lmo0927His6-T307A; Lmo0927-T307A with C-terminal His-tag under native
promoter control; CamR
This study
ANG2931 XL1-Blue pPL3-lmo0927His6-S486A; Lmo0927-S486A with C-terminal His-tag under native
promoter control; CamR
This study
ANG2932 XL1-Blue pPL3-lmo0927His6-N488A; Lmo0927-N488A with C-terminal His-tag under native
promoter control; CamR
This study
ANG2933 XL1-Blue pPL3-lmo0927His6-H489A; Lmo0927-H489A with C-terminal His-tag under native
promoter control; CamR
This study
ANG2934 XL1-Blue pPL3-lmo0927His6-AAA; Lmo0927-AAA with C-terminal His-tag under native
promoter control; CamR
This study
ANG2935 XL1-Blue pProEX-eLtaSLm-T307A; plasmid for expression of eLtaSLm-T307A variant; AmpR This study
ANG2936 XL1-Blue pProEX-eLtaSLm-S486A; plasmid for expression of eLtaSLm-S486A variant; AmpR This study
ANG2937 XL1-Blue pProEX-eLtaSLm-N488A; plasmid for expression of eLtaSLm-N488A variant; AmpR This study
ANG2938 XL1-Blue pProEX-eLtaSLm-H489A; plasmid for expression of eLtaSLm-H489A variant; AmpR This study
ANG2939 XL1-Blue pProEX-eLtaSLm-AAA; plasmid for expression of eLtaSLm-AAA variant; AmpR This study
ANG2940 Rosetta pProEX-eLtaSLm-T307A; strain for overexpression of eLtaSLm-T307A variant; AmpR This study
ANG2941 Rosetta pProEX-eLtaSLm-S486A; strain for overexpression of eLtaSLm-S486A variant; AmpR This study
ANG2942 Rosetta pProEX-eLtaSLm-N488A; strain for overexpression of eLtaSLm-N488A variant; AmpR This study
ANG2943 Rosetta pProEX-eLtaSLm-H489A; strain for overexpression of eLtaSLm-H489A variant; AmpR This study
ANG2944 Rosetta pProEX-eLtaSLm-AAA; strain for overexpression of eLtaSLm-AAA variant; AmpR This study
ANG1460 SM10 pPL3-lmo0927His6; KanR, CamR This study
ANG2946 SM10 pPL3-lmo0927His6-T307A; KanR, CamR This study
ANG2947 SM10 pPL3-lmo0927His6-S486A; KanR, CamR This study
ANG2948 SM10 pPL3-lmo0927His6-N488A; KanR, CamR This study
ANG2949 SM10 pPL3-lmo0927His6-H489A; KanR, CamR This study
ANG2950 SM10 pPL3-lmo0927His6-AAA; KanR, CamR This study
Listeria monocytogenes strains
10403S StrepR – ANG1263 42
ANG1386 10403Slmo0927; StrepR This study
ANG1411 10403Slmo0927 pPL3; StrepR, CamR This study
ANG1454 10403Slmo0927 pPL3-lmo0927His6; StrepR, CamR This study
ANG2951 10403Slmo0927 pPL3-lmo0927His6-T307A; StrepR, CamR This study
ANG2952 10403Slmo0927 pPL3-lmo0927His6-S486A; StrepR, CamR This study
ANG2953 10403Slmo0927 pPL3-lmo0927His6-N488A; StrepR, CamR This study
ANG2954 10403Slmo0927 pPL3-lmo0927His6-H489A; StrepR, CamR This study
ANG2955 10403Slmo0927 pPL3-lmo0927His6-AAA; StrepR, CamR This study
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indicated temperatures and the growth medium was supple-
mentedwith antibiotics as indicated inTable 1. Plasmids for the
expression of eLtaSLm variants with T307A, S486A, N488A,
and H489A single amino acid substitutions and the triple mutant
S486A/N488A/H489A (AAA variant) were constructed by
QuikChange mutagenesis using plasmid pProEX-eLtaSLm
(strain ANG1449) as template and primer pairs ANG1649/
ANG1650,ANG1651/ANG1652,ANG1653/ANG1654,ANG1655/
ANG1656, and ANG1657/ANG1658. The resulting plasmids
were initially transformed into E. coli strain XL1-Blue yielding
strains ANG2935 to ANG2939 and subsequently transformed
for protein expressing into the E. coli Rosetta strain yielding
strains ANG2940 to ANG2944. Plasmid pPL3-lmo0927His6
(Strain ANG1401) allows for the expression of full-length LtaSLm
with a C-terminal His tag from its native promoter in L. monocy-
togenes (3). This vector was used as template for the construction
of plasmids pPL3-lmo0927His6-T307A, pPL3-lmo0927His6-
S286A, pPL3-lmo0927His6-N488A, pPL3-lmo0927His6-H489A,
pPL3-lmo0927His6-AAA for the expression of the different
LtaSLm variants in L. monocytogenes. The desired mutations were
introduced by SOE PCR. More specifically, plasmid pPL3-
lmo0927His6-T307Awas constructed by amplifying the front and
backof lmo0927 and introducing thedesiredpointmutationusing
plasmid pPL3-lmo0927His6 as template and primer pairs
ANG674/ANG1650andANG676/ANG1649 in twoseparatePCR
reactions. The two fragmentswere subsequently fused in a second
round of PCR using primers ANG674/ANG676. The resulting
product was digested with PstI and SalI and ligated with vector
pPL3 that has been cut with the same enzymes. Plasmids
pPL3-lmo0927His6-S286A, pPL3-lmo0927His6-N488A, pPL3-
lmo0927His6-H489A, and pPL3-lmo0927His6-AAA were con-
structed using the same strategy and primers ANG1652 to
ANG1658as listed inTable2.The resultingplasmidswere initially
recovered in E. coli strain XL1-Blue yielding strains ANG2930 to
ANG2934 and subsequently transformed along with plasmid
pPL3-lmo0927His6 into E. coli strain SM10 yielding strains
ANG1460 and ANG2946 to ANG2950. Next all plasmids
were conjugated from SM10 into L. monocytogenes strain
10403Slmo0927 using a previously described method (19) but
maintaining the L. monocytogenes 10403Slmo0927 strain at
30 °C throughout the procedure. This yielded L. monocytogenes
strains ANG1454, and ANG2951 to ANG2955, which were
also propagated at 30 °C. The sequences of all inserts were
verified by automated fluorescence sequencing at the MRC
Clinical Sciences Centre Genomics Core Laboratory, Impe-
rial College London.
Protein Expression and Purification—Strains ANG1478
Rosetta pProEX-eLtaPLm (11) and ANG1479 Rosetta pProEX-
eLtaSLm (11) were used for the expression and purification of N
terminally His-tagged eLtaPLm and eLtaSLm proteins, respec-
tively. Protein induction and nickel affinity purification were
performed as previously described (11, 13). The proteins were
further purified by size exclusion chromatography using a
Superdex S200 16/60 column (GE Healthcare) and a 50 mM
Tris-HCl, pH 7.5, 200 mM NaCl, 5% glycerol buffer system for
eLtaSLm and the different alanine substitution variants or 20
mMTris-HCl, pH7.5, for eLtaPLm. Protein-containing fractions
spanning the main peak were pooled and concentrated to10
mg/ml using 10-kDa molecular mass cut-off Amicon filtration
devices (Millipore), if not otherwise stated. These proteins
were subsequently used in structural studies. eLtaS variants
with T307A, S486A,N488A, andH489A single amino acid sub-
stitutions and a S486A/N488A/H489A (AAA variant) triple
mutantwere expressed inE. coli strainsANG2940 toANG2944
(Table 1). L. monocytogenes strain 10403S pPL3-LtaSLm-His6
(ANG1424) (3) was used for the expression and purification of
eLtaSLm from the native host.
Purification of Native eLtaSLm from L. monocytogenes Cul-
ture Supernatant and Mass Spectrometry Analysis—The L.
monocytogenes strain 10403S pPL3-LtaSLm-His6 (ANG1424)
(3), which contains a plasmid for the expression of the C termi-
nallyHis-tagged LtaSLm variant, was used for the purification of
the secreted eLtaSLm fragment directly from Listeria culture
supernatant. This strain was grown overnight in 6 liters of BHI
medium. The bacterial cells were pelleted by centrifugation for
10 min at 7,000  g and the cleared culture supernatant was
filtered and loaded into a nickel-nitrilotriacetic acid column for
protein purification, as previously reported (16). The elution
fractions containing the C terminally His-tagged eLtaSLm pro-
tein were pooled together and concentrated to a final volume of
50 l at 0.5 mg/ml using a 10-kDa molecular mass cut-off
Centricon. The sample wasmixedwith an equal volume of pro-
tein loading buffer and 5 g of protein separated on a 12%
SDS-PAGE gel alongside 100 g of eLtaSLm protein produced
and purified from E. coli strain ANG1479. Protein bands were
visualized by Coomassie staining. The eLtaSLm protein bands
were excised from the gel, digested with chymotrypsin, and
subjected to mass spectrometry analysis at the TAPLIN Mass
TABLE 2
Primers used in this study
Restriction sites are underlined.
Number Name Sequence
ANG674 5-PstI-Lmo0927-withP AACTGCAGCTAGCAGACTTCCATTCCAAATGGTTC
ANG676 3-SalI-Lmo0927-C-His ACGCGTCGACTTAGTGATGGTGATGGTGATGaccTTTATCGGATGAATCAGTTGATTTTTTC
ANG1649 5-Lmo0927-T307A CCACCAAACTGGACAAGGGAAAGCAGCTGACTCCGAAATGTTAC
ANG1650 3-Lmo0927-T307A GTAACATTTCGGAGTCAGCTGCTTTCCCTTGTCCAGTTTGGTGG
ANG1651 5-Lmo0927-S486A GTACGGTGACCATTATGGTATTGCCGACAACCATGAAGAAGCAATG
ANG1652 3-Lmo0927-S486A CATTGCTTCTTCATGGTTGTCGGCAATACCATAATGGTCACCGTAC
ANG1653 5-Lmo0927-N488A GACCATTATGGTATTTCCGACGCCCATGAAGAAGCAATGACAAAAATTC
ANG1654 3-Lmo0927-N488A GAATTTTTGTCATTGCTTCTTCATGGGCGTCGGAAATACCATAATGGTC
ANG1655 5-Lmo0927-H489A CCATTATGGTATTTCCGACAACGCTGAAGAAGCAATGACAAAAATTCTTG
ANG1656 3-Lmo0927-H489A CAAGAATTTTTGTCATTGCTTCTTCAGCGTTGTCGGAAATACCATAATGG
ANG1657 5-Lmo0927-AAA GTACGGTGACCATTATGGTATTGCCGACGCCGCTGAAGAAGCAATGACAAAAATTCTTG
ANG1658 3-Lmo0927-AAA CAAGAATTTTTGTCATTGCTTCTTCAGCGGCGTCGGCAATACCATAATGGTCACCGTAC
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spectrometry facility (Harvard Medical School, Boston, MA).
The expected active site threonine containing peptide FHQT-
GQGKTADSEM (T catalytic threonine) has a calculated mass
of 1536.6 Da when unmodified or 1616.6 Da with a phosphor-
ylated threonine residue.
Protein Crystallization and Structure Determination—The
solubility of eLtaPLmwas 120mg/ml in 20mMTris-HCl, pH7.5,
buffer and most crystallization drops remained clear in the ini-
tial screens. To decrease the solubility, the protein was sub-
jected to Lys-methylation (20). Crystals appeared after 7–10
days at 4 °C in 100 mM sodium cacodylate buffer, pH 5.4, 100
mM MgCl2, 33% PEG2000 at a protein concentration of 40
mg/ml. Crystals were flash cooled in liquid nitrogen without
additional cryoprotection. Non-methylated protein alone
failed to produce crystals under these conditions. However,
macro-seeding or micro-seeding using the methylated protein
promoted crystallization of the non-methylated protein.
Therefore a methylated seed stock, stored at stored at 4 °C, was
routinely used for seeding. Data were collected at the SOLEIL
synchrotron at the PROXIMA1 beamline (Saint-Aubin,
France) from a single crystal at 100 K. The crystal belonged to
space group P1with unit cell parameters a 53.20Å, b 53.70
Å, c  85.07Å;   71.57°,   87.89°,   65.12°. A mini-
goniometer was used to obtain high completeness in all resolu-
tion shells. Data were indexed with XDS (21) and reduced with
SCALA (21, 22) to 1.75-Å resolution. The Rfree set was gener-
ated randomly in UNIQUE (23). The structure was solved by
molecular replacement using PHASER as implemented in
PHENIX AutoMR (24) using, after side chain pruning and
ligands removal in SCULPTOR (24), the S. aureus eLtaS struc-
ture as model (PDB 2W5Q). Initial refinement and model
buildingwere performed in PHENIXAutoBuild and completed
by cycles of reiterated manual building in COOT (25) and
refinement in REFMAC (26). Structure validation was per-
formed using MOLPROBITY (27).
Crystals of eLtaSLm grew in 5–7 days at 20 °C in 0.64 M
sodium acetate, pH 4.6, 4% PEG3350, 100 mMMgCl2 and were
cryo-protected with 25% PEG400 before flash-cooling in liquid
N2. A micro-seeding technique was employed to improve the
crystal size (28) and crystallization trials were repeated in the
same buffer conditions but lowering the protein concentration
to 5 mg/ml. For the GroP co-crystallization experiments, the
protein was incubated for 10 min at room temperature with a
final concentration of 50 mMGroP. The crystals obtained from
the co-crystallization were further soaked for 5 min in crystal-
lization buffer supplemented with 25% PEG400 and 50 mM
GroP before flash cooling in liquid N2. Data collection of the
apo-eLtaSLm was performed at the Diamond Light Source syn-
chrotron, beamline I24 (Didcot, Oxford, UK), from a single
crystal at 100 K. The apo-structure of eLtaSLm belonged to the
space group P41212 with unit cell dimensions of a b 119.76
Å, c  473.91 Å;       90.0°. The data were indexed,
scaled, and Rfree was generated randomly in UNIQUE (23). The
structure was solved by molecular replacement using BALBES
(29) and the B. subtilis eLtaSBs structure (PDB code 2W8D) as a
startingmodel. Rigid body and restrained refinement produced
a drop of Rfactor and Rfree from 42 and 43% to 25 and 31%,
respectively. The structure was refined and validated as
described above for eLtaPLm.
The data collection of the eLtaSLm-GroP complex was per-
formed at the Diamond Light Source synchrotron beamline
I04-1 (Didcot, Oxford, UK) from a single crystal at 100 K. The
crystals belonged to the space group P212121 with unit cell
dimensions of a  119.25 Å, b  119.63 Å, c  472.66 Å;  
  90.0°. Indexing was performed in XDS and data merg-
ing was performed in SCALA and TRUNCATE (23) H- and
L-test analysis in TRUNCATE highlighted the presence of
pseudo-meroheydral twinning. TheRfree set was generated ran-
domly in UNIQUE and the structure was solved by molecular
replacement in PHASER using apo-eLtaSLm as a model. Ten
cycles of rigid body refinement (10.0–6.0 Å) followed by 10
cycles of restrained refinement in REFMAC gave an R value of
23.6% and Rfree of 25.0%. Twin refinement in REFMAC high-
lighted a twin fraction of 9% with twinning operator k, h, -l.
Therefore the twin option was kept for the whole refinement
process, which was iterated with manual building in COOT.
The final step of the refinement with rotamer optimization was
performed in PHENIX, which did not detect any twinning.
Composite omit maps were calculated in PHENIX and used to
orient the terminalOHgroup ofGroP. Structure validationwas
performed using MOLPROBITY. Ligand coordinate and dic-
tionary files were generated and regularized in JLIGAND (30).
Anomalous maps were generated using the SFTOOLS (23) and
visualized in PYMOL. The statistics for all data sets are shown
in Table 3.
One-dimensional 1H NMR Analysis of eLtaPLm—10 mg of
eLtaPLm in 1 ml of 20 mM Tris-HCl, pH 7.5 buffer, was used for
the one-dimensional 1H NMR analysis. 10% D2O was added to
the protein sample and the spectra were recorded at 800 MHz
at 37 °C before and after the addition of 10 mM EDTA final
concentration.
Modeling of the GroP Trimer in the Catalytic Site of
eLtaSLm—The coordinate and restraint files of the GroP trimer
in its energy minimized form were generated with JLIGAND
(30). Superposition of the coordinates of the GroP trimer with
the eLtaS-GroP complexes was performed in PYMOL.
Enzyme Activity Assay—The activity of wild-type eLtaSLm
and eLtaSLm variants T307A, S486A, N488A, H489A, and
S486A/N488A/H489A was determined as previously reported
(11). Briefly, 4 g of the fluorescently labeled NBD-PG lipid
substrate was incubated for 3 h at 37 °Cwith 30g of enzyme in
10 mM sodium succinate buffer, pH 6.0, adjusted to an ionic
strength of 50 with NaCl and 10 mMMnCl2. The lipid reaction
products were subsequently extracted with chloroform and
methanol, separated by thin layer chromatography, and the sig-
nal of the NBD-DAG hydrolysis product quantified as previ-
ously described (11). Each TLC plate contained a negative no-
enzyme control lane to determine the background signal, as
well as a wild-type eLtaSLm enzyme reaction, which was for
normalization purposes set to 100%. The activity of the differ-
ent variants was calculated as percentage of activity compared
with the wild-type control reaction. Four independent experi-
ments with two different protein purifications were performed
and the average percentage of activity and standard deviation
were plotted.
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LTA and Protein Detection byWestern Blot—The different L.
monocytogenes strains were grown overnight at 30 °C in BHI
medium. Sample analysis for the detection of LTA or the His-
tagged LtaS variants by Western blot was performed as previ-
ously described (3).
Listeria Growth Curves and Microscopy Analysis—The indi-
cated L.monocytogenes strains were grown overnight at 30 °C
in BHImedium. The next day, the cultures were back diluted to
anA600 of 0.05, incubated at 37 °Cwith shaking, and growthwas
monitored by determiningA600 readings at timed intervals. For
microscopy analysis, the different L. monocytogenes strain was
propagated for at least 6 h at 37 °C in BHI medium. Subse-
quently culture aliquots were adjusted to an A600 of 0.5 and
analyzed by phase-contrast microscopy using a Nikon Eclipse
TS100microscope with a20 objective. Images were recorded
using a Sony HDR-CX11 high-definition camcorder mounted
onto the microscope. Two independent microscopy experi-
ments and three independent growth curves were performed
and representative results are shown.
Bioinformatics and Sequence Analysis—Sequences homolo-
gous to the full-length LtaS and LtaP sequences were retrieved
from the RefSeq microbial non-redundant database (31) using
PSI-BLAST (32) with an E-value cutoff 1e-40. Sequences were
filtered to have an alignment length of at least 400 residues, an
identity of at least 28.7%, and similarity of 48.5% to either LtaS
or LtaP. These cutoff values were chosen as they are the
sequence identity and similarity between LtaS and LtaP.
Sequences with a higher similarity to LtaP than LtaS were
assigned to a primase-like sequence list (50 sequences), whereas
sequences with a higher similarity to LtaS were assigned to a
synthase-like list (1038 sequences). The LtaP and LtaS
sequences were separately aligned using MUSCLE (33) and
then combined using MUSCLE profile-profile alignment. The
phylogenetic tree using the combined alignment (having
removed any columns not aligned to either LtaS or LtaP) was
generated using the programPROML fromPHYLIP version 2.3
(34) and plotted using the R package APE (35). All logo plots
were produced using WebLogo (36). For the PSICOV (37)
amino acid covariation analysis a new larger alignmentwas pro-
duced of LtaSLm homologous retrieved from the non-redun-
dant database using PSI-BLAST and an E-value cutoff of 1010.
These sequences were individually aligned to the LtasSLm
sequence using the BLOSUM62 matrix and Smith-Waterman
algorithm, insertions were removed and pairwise alignments
were combined to produce a multiple sequence alignment.
Redundant sequences and sequences covering less than 60%
of the LtaSLm sequence were removed resulting in 6943
final sequences. This final alignment was subsequently ana-
lyzed using the residue contact prediction program PSICOV
(37).
TABLE 3
Dataset statistics
The information for the last shell of resolution is given in parentheses.
eLtaP apo eLtaS apo eLtaS-GroP
Synchrotron Soleil Diamond Diamond
Beamline Proxima1 I24 I04–1
Space group P1 P41212 P212121
a, b, c (Å) 53.20 119.76 119.25
, ,  (o) 53.70 119.76 119.63
85.04 473.91 472.66
71.63 90.00 90.00
76.78 90.00 90.00
65.12 90.00 90.00
Resolution (Å) 47.96 (1.84-1.75) 106.88 (3.16-3.00) 48.71 (2.32-2.20)
Rmergea 0.069 (0.501) 0.117 (0.560) 0.089 (0.459)
Rpim b (all I and I) 0.040 (0.293) 0.062 (0.318) 0.052 (0.265)
I	/SD I	 10.7 (2.5) 8.6 (2.3) 11.5 (2.7)
Completeness (%) 94.8 (92.6) 90.7 (84.6) 98.2 (95.7)
Redundancy 3.8 (3.8) 4.0 (3.5) 3.8 (3.8)
No. reflections 293,738 (41,866) 257,649 (29941) 1,285,177 (180393)
No. unique 77,013 (11,049) 63,877 (8,525) 335,456 (47,358)
Rfactor c 0.178 (0.296) 0.222 (0.319) 0.178 (0.208)
Rfree d 0.207 (0.330) 0.260 (0.376) 0.214 (0.237)
No. atoms 7,119 16,745 40,238
Protein 6,604 16,740 37,131
Water 481 2,997
Ligands 34 5 110
Average B-factors (Å2) 31.4 50.9 33.1
Protein 30.9 50.9 33.0 (30.6)e
Waters 37.0 33.7
Ligands 44.7 45.5 38.6
Root mean square deviations
Bond lengths (Å) 0.009 0.006 0.007
Bond angles (°) 1.23 0.93 1.07
Ramachandran most favored (%) 97 97 98
Ramachandran additional allowed (%) 3 3 2
Ramachandran outliers (%) 0 0 0
PDB code 4UOP 4UOO 4UOR
aRmerge 
h
l Ihl Ih	/
h
l Ih	, where Ihl is the Ith observation of reflection h and Ih	.
bRpim as described in Ref. 43.
c Rfactor 
hFobs(h) Fcal(h)/
hFobs(h), where Fobs(H) Fcal(h) are the observed and calculated structure factors for reflection h, respectively.
dRfree factor was calculated same as Rfactor using 5% reflections, which were selected randomly and omitted from refinement.
e B-factor calculated excluding the disordered monomer K.
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RESULTS
Apo-structures of eLtaPLm and LtaSLm—To identify differ-
ences between LTA synthase and primase enzymes, the soluble
extracellular enzymatic domains eLtaPLm and eLtaSLm were
overexpressed and purified from E. coli and their crystal struc-
tures were determined at 1.75- and 3.0-Å resolution, respec-
tively. Although both enzymes were monomers in solution, as
assessed by size exclusion chromatography, eLtaPLm crystal-
lized with two molecules in the asymmetric unit and eLtaSLm
with five molecules in the asymmetric unit (Table 3). The over-
all structures of eLtaSLm and eLtaPLm are very similar (root
mean square deviation  1.4 Å for C atoms). Both comprise
an / core and a C-terminal part of four anti-parallel
-strands and a long -helix (Fig. 1). As predicted, both
enzymes are similar to eLtaSSa (PDB code 2W5Q) and eLtaSBs
(PDB code 2W8D) with a root mean square deviation on C
atoms of 1.7 Å for eLtaPLm and 0.9 Å for eLtaSLm. Although the
electrostatic surface potentials of eLtaSLm and eLtaPLm are sim-
ilar around the / core at the N-terminal end, there are sub-
stantial differences in cavity size and surface charge distribu-
tion around the catalytic centers (Fig. 2, A and B).
A structure/sequence comparison of the two enzymes high-
lighted two sequence insertions in LtaP that form two extended
loops (residues 544–552, loop 1; residues 561–570, loop 2),
which interact with the long helix 18 (Figs. 1 and 2). There is
no sequence conservation in loop 1 and loop 2 between eLtaPLm
and eLtaSLm except for the salt bridge formed by residues Asp-
600 andArg-545, which correspond to Asp-616 andArg-576 in
the synthase enzyme. The insertion loop 2 in eLtaPLm forms a
negatively charged protrusion, which is repositioned through
Phe-566 on 18 by 2 Å compared with eLtaSLm. This also
leads to the formation of a surface groove, which extends to the
catalytic site (Fig. 2C). In eLtaSLm, this surface groove is con-
stricted by Lys-306, which form a hydrogen bond with Tyr-483
(Fig. 2D). The specific loop 1 and loop 2 sequence insertions are
conservedwithin primase homologues (Fig. 2, E and F) suggest-
ing that the resulting surface features are specific for the func-
tion of primase enzymes.
TheCatalytic Threonine Is Unmodified in theNatural Host—
The catalytic residue of LtaS-type enzymes is a highly con-
served Thr residue that in the B. subtilis eLtaSBs structure is
phosphorylated but unmodified in the S. aureus eLtaSSa struc-
ture (13, 18). In this study, we found that Thr-307 in eLtaSLm is
phosphorylated, whereas the corresponding residueThr-279 in
eLtaPLm is unmodified (Fig. 1). To gain insight into the physio-
logical relevance of thismodification, a C terminallyHis-tagged
LtaSLm variant was expressed in L. monocytogenes and the
cleaved eLtaSLm domain was purified from the culture super-
natant. The purified protein was digested with chymotrypsin,
and peptide fragments were analyzed by electron spray mass
spectrometry. This analysis showed that for eLtaSLm expressed
in E. coli the catalytic Thr is mostly phosphorylated (73%),
whereas only 2% of the protein purified from the natural host is
phosphorylated (Fig. 3). These data suggest that phosphoryla-
tion of the catalytic Thr is not physiological but is likely a result
of expression in a heterologous host. However, as shown below
this modification is likely a mimic of an enzyme-substrate
intermediate.
Preferential Binding ofMn2 to the ConservedMetal Binding
Site—LtaS-type proteins aremetal-dependent enzymes and the
highest in vitro enzyme activity is observed in the presence of
Mn2 (11, 17). Our data show that the metal binding site is
identical in the LtaSLm and LtaPLm structures. In previous LtaS
crystal structures both Mn2 and Mg2 were identified in the
metal binding site near the catalytic threonine, facilitating
phosphatidylglycerol hydrolysis (13, 18). As the crystallization
FIGURE 1. Crystal structures of apo-eLtaPLm and apo-eLtaSLm. Schematic representation of the crystal structures of eLtaPLm (A) and eLtaSLm (B) with close
ups of the catalytic Thr residues (left panel) and loop regions (right panel). The structural differences in the loop regions between eLtaPLm and eLtaSLm are
highlighted in red and black, respectively. The 2Fo Fc electron density map (1.0 root mean square deviation) of Thr-279 in eLtaPLm is highlighted in blue and
the omit Fo Fc map (3.0 root mean square deviation) of the phospho-Thr-307 in eLtaSLm is highlighted in green.
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buffer for both Listeria proteins contained a high MgCl2 con-
centration, it is likely thatMg2 is present in the active center in
our structures. To determine the metal preference of the
enzymes, crystallization trials were set up in the absence of any
addedmetal ion. Although the eLtaPLm protein did not crystal-
lize under these conditions, one-dimensional 1H NMR experi-
ments showed an increase in peak sharpness upon addition of
EDTA, suggesting the presence of a paramagnetic ion such as
Mn2 (Fig. 4A). Although the eLtaSLm crystals grown in the
absence of any added metal ion diffracted only to 6.4 Å, anom-
alous differencemaps showed a strong anomalous peak consist-
ent with the presence of a boundMn2 ion after expression and
purification (Fig. 4B). Together our data provide evidence for
preferential Mn2 binding of both eLtaPLm and eLtaSLm, in the
FIGURE 2. A and B, comparison of the catalytic pocket of eLtaPLm and eLtaSLm. Surface potential representation (blue, positive; red, negative;white, hydropho-
bic) of theareaaround thecatalytic siteof eLtaPLm (A) andeLtaSLm (B). The catalytic pocketof eLtaPLm is restricted through thehighlightedaminoacidsMet-396
and Ile-458 and therefore significantly smaller andmore hydrophobic than in eLtaSLm. C andD, surface potential representation of eLtaPLm (C) and eLtaSLm (D)
structureswith insertion loop regionsboxedandahydrophobicgroove (white) stretching from loop2 to theactive site ineLtaPLmas indicated.EandF,web logo
motif for the insertion loop 1 (E) and insertion loop 2 (F) region of the top 1090 LtaS-type sequences shown on top and theweb logomotif for the 51 LtaP-type
sequences shown below, using amino acid numbering for LtaPLm. The dimension of the letters in WebLogos are directly proportional to the degree of
conservation of the given residue.
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absence of added metals consistent with previous biochemical
activity measurements.
Identification of GroP Binding Sites in eLtaSLm—LtaS-type
enzymes belong to the arylsulfatase group of enzymes and the
reaction mechanism of other members of this class of enzymes
proceeds through the formation of a covalent enzyme-sub-
strate intermediate. In the case of sulfatases, a post-translation-
ally modified cysteine residue, a hydroxyformylglycine, is sul-
fated during catalysis (38).We previously speculated that LtaS-
type enzymes also form a covalent GroP-Thr intermediate as
part of the reaction mechanism (13). Although we show here
that the phosphorylation of the active site Thr residue observed
in the eLtaSLm structure does not occur in the native host (Fig.
3), its presence in E. coli could, however, mimic such a covalent
enzyme substrate intermediate. To provide additional experi-
mental evidence for the formation of a covalent GroP-Thr
intermediate, we performed co-crystallization and crystal soak-
ing experiments with the eLtaSLm and PG lipid substrates with
short chain fatty acids. However, co-crystallization experi-
ments failed to produce crystals and crystal-soaking experi-
ments abolished the diffraction power of the crystals. Next, co-
crystallization and soaking experiments were performed with
GroP, the hydrolysis product of the lipid substrate PG, and the
structure was solved from crystals containing 11 molecules in
the asymmetric unit.
Using this approach, extra electron density was observed in
eachmonomer within the catalytic site (Fig. 5). Similar as in the
apo-structure, it was possible to build a phosphate group into a
density extending fromThr-307 (Fig. 5). The phosphate oxygen
binds to two structurally conserved water molecules, Trp-360,
His-422, and a Mg2 ion that is in turn further coordinated by
Glu-263, Asp-481, and His-482 (Fig. 6, A and B). Additional
difference electron density was observed in each monomer at
the entrance of the catalytic pocket, into which a GroP mole-
cule could be built (Fig. 5). In all chains, the phosphate group of
the GroP molecule in this second site formed hydrogen bonds
with residues Ser-486, Asn-488, and His-489 (Fig. 6, A and B).
In eight molecules in the asymmetric unit an additional hydro-
gen bondwas observed between the terminal hydroxyl group of
GroP and a water molecule (W1), which in turn forms a hydro-
gen bond with Tyr-483 (Fig. 6B). In a previous study, the co-
crystal structure of the S. aureus active site variant eLtaSSa-
T300A with a GroP molecule within the active center was
determined (PDB code 2W5R) (13). The overlay of the catalytic
sites of the GroP-eLtaSSa-T300A and the GroP-eLtaSLm struc-
tures revealed that the GroP molecule within the active center
FIGURE 3. Phosphorylation state of active site Thr as determined by mass spectrometry. A, eLtaSLm was purified from the E. coli cytoplasm or B, directly
from the supernatant of a L. monocytogenes culture, separated on an SDS-PAGE gel, and subjected to a chymotrypsin digest andmass spectrometry analysis.
The mass spectrometry traces corresponding to the active site containing peptide are shown for eLtaSLm purified from E. coli (A) or L. monocytogenes (B). The
expected active site threonine containing peptide FHQTGQGKTADSEM (T, catalytic threonine) has a calculatedmass of 1536.6 Dawhen unmodified or 1616.6
Da with a phosphorylated Thr residue. The fraction of protein with a phosphorylated active site Thr was estimated based on the intensity of the mass
spectrometry signal and is indicated in % in each panel.
FIGURE4.Characteristics of enzyme-boundmetal.A, one-dimensional 1HNMR spectra of eLtaPLm in the absenceor presenceof EDTAone-dimensional NMR
spectra of purified eLtaPLm protein recorded on a 800 MHz magnet at 37 °C before and after addition of 10 mM EDTA. B, anomalous electron density map of
eLtaSLm. eLtaSLm crystals were grown in the absence of any addedmetal ions and data collected close to theMn
2 edge (1.28 Å). TheDANOSigDANOelectron
density map (shown in purple) confirms the presence of a Mn2 ion.
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(referred to as GroP1) superposed with the phosphothreonine
and the conservedwatermoleculesW2andW3 in eLtaSLm (Fig.
6C). Therefore, the phosphorylated Thr likely mimics a cova-
lent GroP-Thr intermediate. The distance between the phos-
phorylated Thr and the terminal hydroxyl group of the GroP2
molecule bound at the entrance of the catalytic pocket is6.3
Å, which is compatible with the length of one intervening GroP
molecule. To test whether an additional GroP molecule could
fit into this space, a GroP trimer model was generated in silico
and fitted into the eLtaSLm structure using the experimental
electron densities of the phosphothreonine andGroP as a guide
(Fig. 6D). Our modeling showed that a GroP could fit in the
intervening space suggesting that the growing PGP LTA chain
could be bound in a similarmanner during the catalytic cycle of
eLtaSLm. The nature of the surface potential of the oligo-GroP
binding groove further supports this conclusion (Fig. 6E). A
series of ordered water molecules spans the catalytic site of
eLtaSLm from residue His-353 to the trapped GroP2 molecule.
The positions of these water molecules are conserved across all
11 monomers within a crystallographic unit and trace the posi-
tion of the modeled GroP trimer (Fig. 6).
The Second GroP Binding Site in eLtaSLm Is Essential for
Enzyme Function—To test the functional requirement of the
second GroP binding site, we mutated residues Ser-486, Asn-
488, andHis-489 to alanines individually or in combination and
tested the mutant enzymes for their ability to produce LTA
(Fig. 7). The different variantswere expressed asC-terminalHis
tag fusion proteins in the L. monocytogenes strain 10403SltaS,
which contains a deletion of the native ltaS gene. As negative
controls, an empty vector or a vector for the expression of the
catalytic site variant T307A (pPL3-ltaST307A-His6) were intro-
duced into 10403SltaS and as positive control a vector for
expression of wild-type LtaS (pPL3-ltaSHis6). Expression of all
LtaS variants was confirmed by Western blot. As previously
reported forWT LtaSLm (3), all GroP binding site variants were
cleaved and the eLtaS fragment was detected in the culture
supernatant as well as in the cell wall-associated fraction (Fig.
7A). The active site T307A variant remained unprocessed and
the full-length protein was observed in the cell wall-associated
fraction (Fig. 7A). In a previous study, a similar accumulation of
the full-length protein was observed in S. aureus for the cata-
lytic site variant (13), suggesting that an enzyme/substrate
intermediate is required to position the enzyme for efficient
processing. However, it should also be noted that the protein
processing step does not serve as an enzyme activation step; to
the contrary, based on experiments performed in S. aureus it
has been proposed that the LtaS cleavage step serves as amech-
anism to inactivate the enzyme (16).
FIGURE 5.GroP/eLtaSLm co-crystal structure. A, ribbon representation of the active site of eLtaSLm with bound phosphate and a GroP molecule in a second
site, as observed in chains B, C, D, F, H, I, J, and K. The phosphate group is covalently linked to the catalytic Thr-307 and GroP is bound at the entrance of the
catalytic site. The omit Fo  Fc electron density map (3.0 root mean square deviation) of the phospho-threonine (T307) and GroP are shown in green. B,
electrostatic surfacepotential representation (blue, positive; red, negative) around the catalytic site showing the chargedistribution surrounding thephospho-
Thr-307 and theGroPmolecule.C, ribbon representation of the active site of eLtaSLmwith boundphosphate and aGroPmolecule in a second site (as observed
in chains A, E, and G) and D, the corresponding surface potential representation.
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As expected, LTA production was restored to wild-type lev-
els in the positive control strain 10403SltaS pPL3-ltaSHis6,
whereas no LTA-specific signal was detected when extracts
from the negative control strains were analyzed by Western
blot using a polyglycerolphosphate-specific monoclonal LTA
antibody (Fig. 7A). Expression of the S486A/N488A/H489A
variant (LtaSAAA) did not restore LTA production, revealing an
essential function of the secondGroP binding site for LTA pro-
duction. Analysis of the single amino acid variants showed that
residues Ser-486 and His-489, but not Asn-488 are important
for the LTA polymerization step (Fig. 7A).
For successful LTA production, PG substrate hydrolysis and
the GroP transfer reaction must take place. To determine
whether the second GroP binding site is required specifically
for PG hydrolysis, the WT and different eLtaS variants were
produced in E. coli, purified, and used for in vitro enzyme reac-
tions with fluorescently labeled NBD-PG lipid as substrate. As
expected, mutating the catalytic Thr-307 residue abolished
enzyme activity (Fig. 7B). The S486A and N488A variants
retained the ability to hydrolyze PG, but the activity dropped by
50% compared with wild-type eLtaSLm. The H489A and
S486A/N488A/H489A (AAA) variants showed a marked
decrease in activity to around 20% of WT (Fig. 7B). These data
show that the second GroP binding site, in particular residue
His-489, is also important for the PG hydrolysis step. The
S486A variant, however, is of particular interest as this variant
retains significant PG hydrolysis activity, whereas the PGP
polymerase activity is nearly abolished. We would suggest that
this is due to the inability of this variant to interact with the
growing PGP chain and therefore, similar to what is observed
naturally in the LTA primase enzyme, the two reactions are
decoupled in this variant.
In a previous study, it has been shown that strain
10403SltaS has growth and morphological defects when
propagated at 37 °C (3). To investigate if expression of any of
the LtaS variants allows for sufficient LTA production to
FIGURE 6. Detailed view of the active center with metal and ligand interactions. A, structural details of the eLtaSLm active site showing the phospho-Thr
intermediate (TPO307) and the metal binding site (as seen in chains A, E, and G). Hydrogen bonds are indicated as gray lines for the metal binding site and as
black lines for the ligands. The water molecules that are conserved in all 11 monomers are represented as spheres in pink. Residues His-353, Arg-362, Trp-360,
His-422, and two water molecules are involved in the binding of the phosphate group and phospho-Thr-307, Glu-263, Asp-481, and His-482 coordinate the
Mg2 ion. TheGroPmolecule,which is 6.5 Å removed from the catalytic residue, formshydrogenbondswith Ser-486, Asn-488, andHis-489. B, structural details
of the eLtaSLm active site showing the phospho-Thr intermediate (TPO307) and the metal binding site (as observed in chains B, C, D, F, H, I, J, and K). The GroP
molecule forms hydrogen bonds with Ser-486, Asn-488, and His-489 like in panel A but in addition it also binds to a water molecule (W1), which in turn forms
ahydrogenbondwithTyr-483.C, superpositionbetween the catalytic siteof eLtaSLmand theGroPmolecules trapped in theeLtaSSa-T300A structure (PDBcode
2W5R). D,model of the eLtaSLm active site bound to a GroP trimer. The GroP timer was produced andminimized with JLIGAND and superposed in PYMOL on
theexperimental crystal structureof theGroP-eLtaSLm co-crystal structure. E,electrostatic potential representationof theeLtaSLmactive sitewith themodeled
GroP trimer. For clarity, the image is rotated by30° around the y axis compared with panel D.
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restore these defects, growth and microscopy analysis was per-
formedwith the complementation strains. As expected the ltaS
deletion strain displayed the expected growth defect and a fila-
mentation phenotype, which could be complemented by intro-
ducing awild-type ltaS allele (Fig. 8). For the other complemen-
tation strains, only expression of the ltaST307A allele did not
restore the growth (Fig. 8A) and morphological defects (Fig.
8B). These results suggest that even if no signal for LTA is
detected by Western blot, limited LTA synthesis must take
place in these strains, which is sufficient to support normal
growth and cell division.
Bioinformatics Analysis and Structure Guided Identification
of LtaP and LtaS Enzyme Family Motifs—To obtain an over-
view of the distribution of LtaP and LtaS-type enzymes among
Gram-positive bacteria and to investigate the conservation of
the structural features identified in this study, bioinformatics
analyses were performed. To this end, homologues to full-
length LtaS and LtaP sequences were retrieved and filtered to
thosewith an alignment length ofmore than 400 residues yield-
ing 1088 sequences. This was done to remove proteins that do
not contain an N-terminal membrane domain and are there-
fore unlikely involved in LTAproduction.Of the 1088 retrieved
sequences, only 50 showed greater homology to LtaP than to
LtaS (supplemental Table S1). Primase family enzymes are
present in the different Listeria species and similar to L. mono-
cytogenes these species also contain an LtaS-type enzyme. This
analysis highlighted that a two-enzyme LTA synthesis system
with highly divergent enzymes as seen in Listeria sp. is not
widely distributed among bacteria (Fig. 9 and supplemental
Table S1). For instance, Bacillus sp. also contain multiple
enzymes, but they are more closely related to one another than
to the two enzymes found in Listeria sp (Fig. 9 and supplemen-
tal Table S1). This could indicate that either a gene duplication
event took place more recently in Bacillus sp. or that the diver-
gent primase-like enzyme was only retained in a few species
such as Listeria, Thermotoga, and Paenibacillus sp. Primase-
like enzymes also appear to be present in a few specific bacterial
strains such as Planococcus donghaensis MPA1U2, Brevibacil-
lus laterosporusLMG, andB. cereus cytotoxisNVH391–98 (Fig.
9 and supplemental Table S1). The latter strain was isolated
from a fatal case of enteritis. It is therefore plausible that the
gene coding for the primase enzymewas acquired through hor-
izontal gene transfer from a Listeria strain by co-inhabiting the
same ecological niche. It is also of note that theThermotoga sp.,
B. laterosporus LMG, and several of the Paenibacillus sp. do not
contain an LtaS-type enzyme and hence are unlikely to produce
an actual LTA polymer.
As shown above, we have identified a second GroP binding
site in LtaSLm and confirmed its importance for LTA produc-
tion experimentally. Next, we analyzed distribution of binding
site residues Ser-486, Asn-488, andHis-489 across LTA synthe-
sis enzymes. Separate alignments were produced for the 1038
LtaS-type sequences and the 50 LtaP-type sequences. Subse-
quently, a logo motif was created to visualize the conservation
of amino acids across the whole enzyme family (data not
shown). As expected, the active site threonine, as well as the
metal binding residues, were highly conserved and present in
both LtaP and LtaS-type enzymes (Fig. 7C). In addition, con-
FIGURE7. Invivoand in vitroactivityofeLtaSLmGroPbindingsitevariants
and bioinformatics analysis of conserved binding residues. A, detection
of LtaSLm protein and LTA by Western blot. Samples of wild-type L. monocy-
togenes 10403S (WT) and the 10403SltaS-derived strains containing an
empty pPL3 vector or expressing the indicated LtaSLm variants as C-terminal
His tag fusion proteins were prepared for Western blot analysis. The LtaS
protein was detected in the supernatant and cell wall-associated fractions
using a His tag-specific antibody and LTA in the cell wall-associated fraction
using a polyglycerolphosphate-specific antibody. B, in vitro enzyme activity
assaywith purifiedWT eLtaSLm and the different eLtaS variants. Enzyme reac-
tions were set up using the fluorescently labeled lipid NBD-PG as substrate.
The reaction products were separated on TLC plates and the NBD-DAG prod-
uct was quantified. Four independent experiments were performed and the
enzyme activity of the eLtaSLm protein (labeled WT in the graph) was set to
100% in each experiment. The relative activity of the different variants com-
paredwithWTeLtaSLmwas calculatedand theaveragevalueandS.D. plotted.
C, sequence logo motif of active site, metal binding, active site GroP (GroP1)
and second GroP (GroP2) binding site residues. The 51 LtaP-like sequences
(top panels) and the 1039 LtaS-type sequences (bottom panels) were
aligned and logomotifs for selected amino acid regions are shown. Active
site residue (*), GroP1 (f), GroP2 (), and metal binding residues (●) are
indicated and amino acid numbering for the respective L. monocytogenes
protein is shown.
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served residues in the active site, which are required for binding
of the GroP molecule within the active center, could also be
identified in both enzyme types (Fig. 7C). The second GroP
binding site residues corresponding to Ser-486 and His-488
in LtaSLm were also conserved, however, only found in LtaS-
type but not in primase-like enzymes (Fig. 7C). Based on our
functional data, which showed that residues Ser-486 and
His-488 are required for LTA production, we suggest that
the absence of these residues is an important factor contrib-
uting to the inability of the LtaP enzyme to produce a PGP
polymer.
DISCUSSION
Model for the Enzyme Reaction Mechanism and LTA Chain
Extension of LtaS-type Enzymes—Our new data presented in
this study combined with previous results allow us to speculate
how the LTA synthesis proceeds. We suggest that the reaction
is initiated by nucleophilic attack of Thr-307 to PG resulting in
the breakage of the phosphoester bond yielding onemolecule of
DAG and a covalent GroP-Thr intermediate (Fig. 10). LtaS
belongs to the alkaline phosphatase superfamily and arylsulfa-
tase family, in which Ser and Thr residues are often phosphor-
ylated to be activated (39). For this reason it has been postulated
that phosphorylation of the catalytic Thr as observed in the B.
subtilis LtaS structure is required for initiation of the reaction
(13, 18). However, we show in the current study that this is not
the case for eLtaSLm. Although the active site threonine residue
is phosphorylated in the eLtaSLm structure (Fig. 1), mass spec-
trometry analysis showed that this phosphorylation is likely an
artifact caused by the purification of the protein from E. coli
extracts as only a very small fraction of the protein obtained
from the natural host L.monocygenes is phosphorylated (Fig. 3).
The threonine phosphorylation is more likely to mimic the
covalent GroP-Thr intermediate.
Next, the covalentGroP-Thr intermediate (GroP donormol-
ecule) has to be attached to the incoming LTA chain (GroP
acceptor molecule). In this study, we identified a second GroP
binding site in the L. monocytogenes LtaS enzyme, which con-
sists of residues S486A, N488A, and H489A. A reanalysis of the
previously published S. aureus and B. subtilis eLtaS revealed
that this binding site is identical in all three enzymes. It can be
speculated that the tip of the LTA chain is bound in a similar
manner to the GroP molecule within this second binding site.
However, for a transfer reaction to occur, the enzyme would
need to undergo a significant conformational change in order
FIGURE 8. Growth and microscopy analysis of wild-type L. monocytogenes, mutant, and complementation strains. A, growth curves. The wild-type L.
monocytogenes strain10403S (WT) and10403SltaS-derived strains containinganemptypPL3vectoror apPL3vectorwith the indicated ltaSalleleweregrown
at 37 °C in BHImedium, A600 readings determined at timed intervals and plotted. B, microscopy analysis. The same strains as used for growth curves in panel A
were analyzed by phase-contrast microscopy following growth at 37 °C.
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for the terminal hydroxyl group to reach the 6.3 Å removed
charged active site threonine. Therefore we hypothesize that
the trapped GroP molecule represents more likely the penulti-
mate GroP subunit of a growing LTA chain (Figs. 6 and 10).
Residues Lys-306 and Tyr-483 were located close to the active
center, and could assist the binding of a terminal GroP subunit
of an incoming chain by coordinating its phosphate group (Fig.
6). No electron density is observed for the side chain of Lys-306
in both theListeria and Staphylococcus eLtaS enzymes, suggest-
ing that the lysine is flexible and therefore could be used for
stabilizing the phosphate group of an incoming terminal GroP
(Fig. 6). It is of note that both Lys-306 and Tyr-483 are con-
served residues among LtaS-type enzymes. In LtaP-type
enzymes, where there is no requirement for binding of incom-
ing GroP chains, these residues are replaced with Asn-278 and
a range of amino acids at position 457 (Figs. 7C).
For the polymerization reaction to occur the proton of the
terminal hydroxyl group of the incoming LTA chain must be
displaced. No obvious candidate residues can be identified in
the vicinity of this terminal GroP or near the bound GroP2.
Previous findings showing that the full-length enzyme is
required in vivo for LTA production highlights a crucial func-
tion of the membrane domain for enzyme function (17). One
hypothesis is that a residue(s) within the transmembrane
domain of the full-length LtaS enzyme could act as a base to
remove a proton from the hydroxyl group of the acceptor GroP
chain. Based on topology predictions, LtaSLm has five trans-
membrane helices and two extracellular loops, which span res-
FIGURE 9. Unrooted phylogenetic tree of representative LtaS and LtaP-type enzymes. 1088 LtaS and LtaP sequence homologues were retrieved as
described under “Experimental Procedures.” An unrooted phylogenetic tree was generated for representative LtaS and LtaP-type enzymes. Thirty of 50
LtaP-like protein sequences are shown in red and 28 of the remaining 1038 LtaS-like sequences are shown in green if the same bacterial stain also contains an
LtaP-like enzymeor inblack if thebacterial strain only contains LtaS-like enzymes. For clarity, themajority of the LtaS-type sequences,whichwould fall onto the
right side of the tree, are not shown. The L. monocytogenes 10403S proteins analyzed in this study are indicated with dots. The scale bar indicates the branch
length unit of the tree as inferred using the programPROML and is the expected fraction of amino acids changed. A complete list of the organisms and RefSeq
accessionnumbers canbe found in supplemental Table S1using the samecolor-codingwithprimase-like sequences shown in redand synthase-like sequences
shown in green or black.
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idues 35 to 48 (extracellular loop 1) and residues 98 to 105
(extracellular loop 2). Strikingly Asp-101 and Phe-102 within
the second loop are highly conserved among LtaS-type
enzymes but not in LtaP (data not shown) suggesting a possible
functional role for these residues; in particular Asp-101 could
act as a base required for the polymerization reaction. Once the
terminal hydroxyl group is deprotonated it can act as a nucleo-
phile to attack the phosphoester of the bound GroP-Thr
assisted by the bound metal (Fig. 10).
To date, no structural information is available for the mem-
brane portion of any of the LTA synthesis enzymes. Previously
it has been reported that hybrid proteins, in which the mem-
brane and extracellular domains of two functional proteins are
swapped, are non-functional suggesting a specific interaction
between the transmembrane and extracellular enzymatic
domains (17). If a direct interaction between the two domains is
crucial for enzyme function, one might expect interacting
amino acids to co-vary within the two domains of LtaS
enzymes. To explore this, a new larger alignment was made
using 6943 sequences from the non-redundant database. Resi-
due contacts were predicted using PSICOV and plotted along-
side experimentally confirmed contacting amino acids based
on the eLtaSLm structure (Fig. 11). Using this analysis, several
residueswithin the transmembrane regionwere predicted to be
in contact with amino acid residues within the extracellular
domain (primarily located in proximity of the active site or at
the back of the molecule), supporting the notion of a physical
interaction between the transmembrane and extracellular
domain.
The LtaPLm and LtaSLm structures determined as part of this
study provide information on the molecular basis for the
restricted enzyme activity and inability of the LtaPLm enzyme to
polymerize LTA chains. Specifically, our work revealed that
LtaPLm has a smaller active site cavity, lacks a second GroP
binding site, and that two conserved loop insertions results in
subtle alterations to surface cavities. These data allowed us to
propose a model on how the incoming LTA chain could bind
during the chain extension step. Supported by bioinformatics
analyses, we further suggest that a crucial catalytic residue for
activating the GroP acceptor chain might be located within the
transmembrane domain. To confirm this and to understand the
functional significance of highly conserved amino acids within
the extracellular loops or the conserved aspartic acid residues
with the fourth transmembrane helix will require further stud-
ies and in particular a structural investigation on the full-length
enzyme.
LTA synthesis enzymes are currently being actively pursued
as target proteins for the development of novel antibiotics and
recently, the first LtaS enzyme inhibitor was identified (4).
Based on our findings, we would suggest that future structure-
based design of LTA synthesis enzyme inhibitors should be
extended to include the second GroP binding site. We envis-
age that targeting this binding site may offer a better chance
of obtaining LtaS-specific inhibitors and decrease the possi-
bility of obtaining compounds that are cross-reactive toward
members of the same protein family such as mammalian
alkaline phosphatases. Expanding the chemical landscape
search to a larger enzyme area might increase the chances of
FIGURE 10. Proposed reaction mechanism of LtaSLm. The active site threonine is polarized by the Mn
2 ion allowing for a nucleophilic attack of Thr-307 to
PG (1) generating the Thr-glycerolphosphate intermediate with the elimination of a DAG molecule (2). In our model the penultimate GroP molecule of the
incoming GroP chain (GroPn) would be held in place within the second GroP binding site. The hydroxyl group of the terminal GroP unit will be deprotonated
by a base (amino acid residue or water) (2) allowing for a nucleophilic attack on the Thr-GroP intermediate to occur (3). The product of the reaction, the LTA
chain extended by one GroP unit, is released and the cycle completed through the deprotonation of the base of the reaction and the catalytic Thr-307 is
repolarized by the metal ion (4).
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discovering new enzyme-specific inhibitors, which could be
used to treat infections caused by important Gram-positive
human pathogens.
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